BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.050
-0.020 (-1.87%)
At close: Sep 25, 2026, 4:00 PM EDT
1.070
+0.020 (1.90%)
After-hours: Sep 25, 2026, 7:22 PM EDT
BioCardia Employees
As of December 31, 2025, BioCardia had 21 total employees, including 17 full-time and 4 part-time employees. The number of employees increased by 1 or 5.00% compared to the previous year.
Employees
21
Change (1Y)
1
Growth (1Y)
5.00%
Revenue / Employee
n/a
Profits / Employee
-$349,476
Market Cap
15.90M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | 1 | 5.00% | 17 | 4 |
| Dec 31, 2024 | 20 | 0 | - | 17 | 3 |
| Dec 31, 2023 | 20 | -16 | -44.44% | 16 | 4 |
| Dec 31, 2022 | 36 | 1 | 2.86% | 30 | 6 |
| Dec 31, 2021 | 35 | 6 | 20.69% | 28 | 7 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Palatin Technologies | 29 |
| Cerenome | 28 |
| Passage Bio | 24 |
| Citius Pharmaceuticals | 23 |
| Lantern Pharma | 16 |
| Kiora Pharmaceuticals | 13 |
| Actuate Therapeutics | 12 |
| Allarity Therapeutics | 8 |
BCDA News
- 4 days ago - BioCardia provides update on near term milestones for CardiAMP, Helix - TheFly
- 4 days ago - BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission - GlobeNewsWire
- 17 days ago - BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 4 weeks ago - BioCardia gets FDA confirmation of Helix meeting minutes - TheFly
- 4 weeks ago - BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-On De Novo Pre-Submission for Approval - GlobeNewsWire
- 6 weeks ago - BioCardia Earnings Call Transcript: Q2 2026 - Transcripts
- 6 weeks ago - BioCardia Quarterly report: Q2 2026 - Filings
- 6 weeks ago - BioCardia Earnings release: Q2 2026 - Filings